title: Fulvestrant: clinical application of an estrogen receptor downregulator.
authors.affiliation: Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA. joyce.oshaughnessy@usoncology.com
authors.forename: Michael
authors.initials: M
authors.lastname: Torosian
authors.forename: Joyce
authors.initials: J
authors.lastname: O'Shaughnessy
authors.forename: Leroy Monroe
authors.initials: LM
authors.lastname: Parker
authors.forename: Charles
authors.initials: C
authors.lastname: Vogel
mesh_terms: D000328:Adult; D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D047072:Aromatase Inhibitors; D001943:Breast Neoplasms / Q000188:drug therapy*; D015536:Down-Regulation; D004958:Estradiol / Q000031:analogs & derivatives / Q000627:therapeutic use*; D020847:Estrogen Receptor Modulators / Q000627:therapeutic use*; D005260:Female; D000077267:Fulvestrant; D017273:Goserelin / Q000627:therapeutic use; D006801:Humans; D013629:Tamoxifen / Q000627:therapeutic use
chemical_list: D018931:Antineoplastic Agents, Hormonal; D047072:Aromatase Inhibitors; D020847:Estrogen Receptor Modulators; D013629:Tamoxifen; D017273:Goserelin; D000077267:Fulvestrant; D004958:Estradiol